Pretransplant serum FT3 levels in recipients predict early non-relapse mortality after myeloablative allogeneic haematopoietic cell transplantation from matched sibling donors

References

• Anasetti C, Logan BR, Lee SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367(16):1487–1496.
   PubMed Web of Science ®Google Scholar
• Pollack SM, O'Connor TPJr, Hashash J, et al. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review. Am J Clin Oncol. 2009;32(6):618–628.
   PubMed Web of Science ®Google Scholar
• Storb R, Gyurkocza B, Storer BE, et al. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2013;31(12):1530–1538.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Storb RF, Sandmaier BM, et al. Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. J Clin Oncol. 2014;32(29):3249–3256.
   PubMed Web of Science ®Google Scholar
• Sato M, Nakasone H, Oshima K, et al. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant. 2013;48(5):698–702.
   PubMed Web of Science ®Google Scholar
• Ueda N, Chihara D, Kohno A, et al. Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(9):1335–1340.
   PubMed Web of Science ®Google Scholar
• Rashidi A, DiPersio JF, Westervelt P, et al. Peritransplant serum albumin decline predicts subsequent severe acute graft-versus-host disease after mucotoxic myeloablative conditioning. Biol Blood Marrow Transplant. 2016;22(6):1137–1141.
   PubMedGoogle Scholar
• Fliers E, Bianco AC, Langouche L, et al. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816–825.
   PubMed Web of Science ®Google Scholar
• Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107(5):708–713.
   PubMed Web of Science ®Google Scholar
• Karadag F, Ozcan H, Karul AB, et al. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir Med. 2007;101(7):1439–1446.
   PubMed Web of Science ®Google Scholar
• Pingitore A, Landi P, Taddei MC, et al. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118(2):132–136.
   PubMed Web of Science ®Google Scholar
• Rozing MP, Westendorp RG, Maier AB, et al. Serum triiodothyronine levels and inflammatory cytokine production capacity. Age (Dordr). 2012;34(1):195–201.
   PubMedGoogle Scholar
• Moura Neto A, Parisi MC, Alegre SM, et al. Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus. Endocrine. 2016;51(1):63–71.
   PubMed Web of Science ®Google Scholar
• Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, et al. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. Eur J Endocrinol. 2011;164(2):147–155.
   PubMed Web of Science ®Google Scholar
• Cerillo AG, Storti S, Kallushi E, et al. The low triiodothyronine syndrome: a strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2014;97(6):2089–2095.
   PubMed Web of Science ®Google Scholar
• Rotondi M, Netti GS, Rosati A, et al. Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure. Clin Endocrinol (Oxf). 2008;68(2):220–225.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen F, Han Y, et al. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies. Biol Blood Marrow Transplant. 2009;15(10):1258–1264.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825–828.
   PubMed Web of Science ®Google Scholar
• Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(8):571–575.
   PubMed Web of Science ®Google Scholar
• Suda S, Muraga K, Kanamaru T, et al. Low free triiodothyronine predicts poor functional outcome after acute ischemic stroke. J Neurol Sci. 2016;368:89–93.
   PubMed Web of Science ®Google Scholar
• Vexiau P, Perez-Castiglioni P, Socié G, et al. The ‘euthyroid sick syndrome': incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. Br J Haematol. 1993;85(4):778–782.
   PubMed Web of Science ®Google Scholar
• Schulte C, Reinhardt W, Beelen D, et al. Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1998;22(12):1171–1178.
   PubMed Web of Science ®Google Scholar
• Moura Neto A, Zantut-Wittmann DE. Abnormalities of thyroid hormone metabolism during systemic illness: the low T3 syndrome in different clinical settings. Int J Endocrinol. 2016;2016(3):2157583.
   PubMedGoogle Scholar
• Farwell AP. Nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):478–484.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Tripepi G, Cutrupi S, et al. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005;16(9):2789–2795.
   PubMed Web of Science ®Google Scholar
• Taki-Eldin A, Zhou L, Xie HY, et al. Triiodothyronine attenuates hepatic ischemia/reperfusion injury in a partial hepatectomy model through inhibition of proinflammatory cytokines, transcription factors, and adhesion molecules. J Surg Res. 2012;178(2):646–656.
   PubMed Web of Science ®Google Scholar
• Henden AS, Hill GR. Cytokines in graft-versus-host disease. J Immunol. 2015;194(10):4604–4612.
   PubMed Web of Science ®Google Scholar
• Teshima T, Reddy P, Zeiser R. Acute graft-versus-host disease: novel biological insights. Biol Blood Marrow Transplant. 2016;22(3 Suppl):11–16.
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Pawlak K, et al. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients. Transplant Proc. 2006;38(10):3509–3513.
   PubMed Web of Science ®Google Scholar
• Videla LA, Fernández V, Cornejo P, et al. Thyroid hormone in the frontier of cell protection, survival and functional recovery. Expert Rev Mol Med. 2015;17:e10.
   PubMed Web of Science ®Google Scholar
• Storek J, Mohty M, Boelens JJ. Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015;21(6):959–970.
   PubMed Web of Science ®Google Scholar
• Anasetti C. Use of alternative donors for allogeneic stem cell transplantation. Hematology Am Soc Hematol Educ Program. 2015;2015(1):220–224.
   PubMed Web of Science ®Google Scholar